| Evolution of a highly active and enantiospecific metalloenzyme from short peptides S Studer, DA Hansen, ZL Pianowski, PRE Mittl, A Debon, SL Guffy, ... Science 362 (6420), 1285-1288, 2018 | 157 | 2018 |
| Ultrahigh-throughput screening enables efficient single-round oxidase remodelling A Debon, M Pott, R Obexer, AP Green, L Friedrich, AD Griffiths, D Hilvert Nature Catalysis 2 (9), 740-747, 2019 | 92 | 2019 |
| Droplet confinement and leakage: Causes, underlying effects, and amelioration strategies AP Debon, RCR Wootton, KS Elvira Biomicrofluidics 9 (2), 2015 | 43 | 2015 |
| Enzymatic bioconjugation: a perspective from the pharmaceutical industry A Debon, E Siirola, R Snajdrova JACS Au 3 (5), 1267-1283, 2023 | 30 | 2023 |
| Computer-guided substrate scope exploration of engineered peptide-modifying biocatalysts E Siirola, A Debon, F Eggimann, R Snajdrova | | 2023 |
| Directed Evolution of Enzymes using Ultrahigh-Throughput Screening A Debon ETH Zurich, 2021 | | 2021 |
| DROPLET FAILURE MODES: CAUSES, UNDERLYING EFFECTS AND AMELIORATION STRATEGIES A Debon, RCR Wootton, KS Elvira | | |
Douglas A. HansenTotus Medicines在 umich.edu 的电子邮件经过验证
